GRTX logo

Galera Therapeutics (GRTX) Company Overview

Profile

Full Name:

Galera Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 7, 2019

Indexes:

Not included

Description:

Galera Therapeutics (GRTX) is a biotechnology company focused on developing innovative treatments for cancer. They aim to improve the effectiveness of radiation therapy by reducing side effects and enhancing tumor control, using their unique drug candidates to support patients undergoing cancer treatment.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Dec 13, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Aug 29, 23 Citigroup
Neutral
Aug 16, 23 HC Wainwright & Co.
Neutral
Aug 10, 23 Piper Sandler
Neutral
Jul 17, 23 HC Wainwright & Co.
Buy
Mar 22, 23 HC Wainwright & Co.
Buy
Feb 21, 23 Piper Sandler
Overweight
Feb 16, 23 HC Wainwright & Co.
Buy
Feb 16, 23 B of A Securities
Buy
May 27, 22 B of A Securities
Underperform
Dec 20, 21 Citigroup
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Galera Therapeutics?
  • Does Galera Therapeutics pay dividends?
  • What sector is Galera Therapeutics in?
  • What industry is Galera Therapeutics in?
  • What country is Galera Therapeutics based in?
  • When did Galera Therapeutics go public?
  • Is Galera Therapeutics in the S&P 500?
  • Is Galera Therapeutics in the NASDAQ 100?
  • Is Galera Therapeutics in the Dow Jones?
  • When was Galera Therapeutics's last earnings report?
  • When does Galera Therapeutics report earnings?
  • Should I buy Galera Therapeutics stock now?

What is the ticker symbol for Galera Therapeutics?

The ticker symbol for Galera Therapeutics is NASDAQ:GRTX

Does Galera Therapeutics pay dividends?

No, Galera Therapeutics does not pay dividends

What sector is Galera Therapeutics in?

Galera Therapeutics is in the Healthcare sector

What industry is Galera Therapeutics in?

Galera Therapeutics is in the Biotechnology industry

What country is Galera Therapeutics based in?

Galera Therapeutics is headquartered in United States

When did Galera Therapeutics go public?

Galera Therapeutics's initial public offering (IPO) was on November 7, 2019

Is Galera Therapeutics in the S&P 500?

No, Galera Therapeutics is not included in the S&P 500 index

Is Galera Therapeutics in the NASDAQ 100?

No, Galera Therapeutics is not included in the NASDAQ 100 index

Is Galera Therapeutics in the Dow Jones?

No, Galera Therapeutics is not included in the Dow Jones index

When was Galera Therapeutics's last earnings report?

Galera Therapeutics's most recent earnings report was on Dec 13, 2024

When does Galera Therapeutics report earnings?

The next expected earnings date for Galera Therapeutics is Mar 28, 2025

Should I buy Galera Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions